Methods: A Medline and Embasy and Cochrane search was conducted considering the literature from 1998 to 2013. Non-English manuscripts and articles on nonhuman subjects as well as studies with an improper study design, case series, and technical report were excluded. Systematic review and all controlled trials involving use of either PRP or PRF in combination with autogenous bone or bone substitute, in sinus augmentation procedures for implant insertion, were included. Outcome measures were histomorphometric parameters evaluating new bone formation and/or implant survival.
Results: Literature analysis showed 2 systematic reviews, 9 controlled trials and 12 randomized controlled trials that fulfilled the inclusion criteria: 2 CCT et 6 RCT papers on PRP with autografts, 1 CCT on PRP with bone substitut (BioOss® ) et 6 RCT (1 FDBA, 1 Β-TCP, and 4 BioOss®) and 3 CCT on PRF with bone substitute (1 FDBA and 2 BioOss®) were identified. Methods of quantifying new bone formation PRP preparation and time of healing differ between studies. Data regarding PRP use in combination with autografts or bone graft substitutes showed conflicting data. Regarding PRF, few non-randomized trials were identified.
Conclusion: Scientific evidence of the PRP and or PRF benefit when used in combination with autografts or bone graft substitutes in sinus augmentation is still limited.